000			02217 a2200637 4500
005			20250518010016.0
264		0	_c20191011
008			201910s 0 0 eng d
022			_a1946-6242
024	7		_a10.1126/scitranslmed.aat5933 _2doi
040			_aNLM _beng _cNLM
100	1		_aScafoglio, Claudio R
245	0	0	_aSodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. _h[electronic resource]
260			_bScience translational medicine _c11 2018
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdenocarcinoma of Lung _xdiagnosis
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aBiological Transport _xdrug effects
650	0	4	_aCell Differentiation
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aFemale
650	0	4	_aGlucose _xmetabolism
650	0	4	_aGlucose Transporter Type 1 _xmetabolism
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice, SCID
650	0	4	_aMice, Transgenic
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aPositron-Emission Tomography
650	0	4	_aPrecancerous Conditions _xmetabolism
650	0	4	_aSodium-Glucose Transporter 2 _xmetabolism
650	0	4	_aSodium-Glucose Transporter 2 Inhibitors _xpharmacology
650	0	4	_aSurvival Analysis
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aVillegas, Brendon
700	1		_aAbdelhady, Gihad
700	1		_aBailey, Sean T
700	1		_aLiu, Jie
700	1		_aShirali, Aditya S
700	1		_aWallace, W Dean
700	1		_aMagyar, Clara E
700	1		_aGrogan, Tristan R
700	1		_aElashoff, David
700	1		_aWalser, Tonya
700	1		_aYanagawa, Jane
700	1		_aAberle, Denise R
700	1		_aBarrio, Jorge R
700	1		_aDubinett, Steven M
700	1		_aShackelford, David B
773	0		_tScience translational medicine _gvol. 10 _gno. 467
856	4	0	_uhttps://doi.org/10.1126/scitranslmed.aat5933 _zAvailable from publisher's website
999			_c29044680 _d29044680